Quotient Clinical Completes Expansion in UK

The new facilities have been inspected and approved for use by the UK regulatory authority and have been awarded Supplementary Accreditation.

Quotient Clinical, a business unit of Quotient Bioresearch, has completed a major expansion of its clinical facilities in Nottingham, UK. The expansion gives Quotient a 50% increase in bed capacity and a dedicated sample processing lab for human ADME studies.

The new facilities have been inspected and approved for use by the UK regulatory authority, the Medicines and Healthcare products Regulatory Agency (MHRA), and have been awarded Supplementary Accreditation.

The facilities will operate under Quotient’s Synthesis-to-Clinic platform in support of human ADME studies, reinforcing the company’s provision of 14C-enabled drug development services including Phase 0 microdose, ivMicrotracer, and human metabolis